Back to People Listing
Faculty

Svati Shah

Associate Professor, Medicine, Nursing and Global Health
School of Medicine
Svati Shah

Summary

Svati H. Shah, MD, MHS, is an Associate Professor of Medicine in the Division of Cardiology, Department of Medicine. She is a board eligible cardiologist and her clinical interests are in genetics, echocardiography, and preventive cardiology. Her research focuses on genetic epidemiology and gene-environment interactions in complex cardiovascular diseases, including dyslipidemia, premature coronary artery disease, aortic stenosis, and peripheral vascular disease. She is also interested in genomic medicine and personalized patient care and has started a complex cardiovascular disease genetics clinic at Duke University Medical Center.

Locations

Projects

Recent Publications

Benjamin, EJ, Muntner, P, Alonso, A, Bittencourt, MS, Callaway, CW, Carson, AP, Chamberlain, AM, Chang, AR, Cheng, S, Das, SR, Delling, FN, Djousse, L, Elkind, MSV, Ferguson, JF, Fornage, M, Jordan, LC, Khan, SS, Kissela, BM, Knutson, KL, Kwan, TW, Lackland, DT, Lewis, TT, Lichtman, JH, Longenecker, CT, Loop, MS, Lutsey, PL, Martin, SS, Matsushita, K, Moran, AE, Mussolino, ME, O'Flaherty, M, Pandey, A, Perak, AM, Rosamond, WD, Roth, GA, Sampson, UKA, Satou, GM, Schroeder, EB, Shah, SH, Spartano, NL, Stokes, A, Tirschwell, DL, Tsao, CW, Turakhia, MP, VanWagner, LB, Wilkins, JT, Wong, SS, Virani, SS, & American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, . (2019, March). Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation, 139 (10), e56-e528.
Gusarova, V, O'Dushlaine, C, Teslovich, TM, Benotti, PN, Mirshahi, T, Gottesman, O, Van Hout, CV, Murray, MF, Mahajan, A, Nielsen, JB, Fritsche, L, Wulff, AB, Gudbjartsson, DF, Sjögren, M, Emdin, CA, Scott, RA, Lee, W-J, Small, A, Kwee, LC, Dwivedi, OP, Prasad, RB, Bruse, S, Lopez, AE, Penn, J, Marcketta, A, Leader, JB, Still, CD, Kirchner, HL, Mirshahi, UL, Wardeh, AH, Hartle, CM, Habegger, L, Fetterolf, SN, Tusie-Luna, T, Morris, AP, Holm, H, Steinthorsdottir, V, Sulem, P, Thorsteinsdottir, U, Rotter, JI, Chuang, L-M, Damrauer, S, Birtwell, D, Brummett, CM, Khera, AV, Natarajan, P, Orho-Melander, M, Flannick, J, Lotta, LA, Willer, CJ, Holmen, OL, Ritchie, MD, Ledbetter, DH, Murphy, AJ, Borecki, IB, Reid, JG, Overton, JD, Hansson, O, Groop, L, Shah, SH, Kraus, WE, Rader, DJ, Chen, Y-DI, Hveem, K, Wareham, NJ, Kathiresan, S, Melander, O, Stefansson, K, Nordestgaard, BG, Tybjærg-Hansen, A, Abecasis, GR, Altshuler, D, Florez, JC, Boehnke, M, McCarthy, MI, Yancopoulos, GD, Carey, DJ, Shuldiner, AR, Baras, A, Dewey, FE, & Gromada, J. (2018, June 13). Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes. Nature Communications, 9 (1), 2252-null.

View All Publications